Cogstate Share Price and Company Fundamentals

-0.020 (-2.381%)
52 week
0.295 - 1.47

Last traded: Today at 5:49 AM

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations across various indications, including Alzheimer's disease, HIV, multiple sclerosis, pediatric and adult oncology, Parkinson's disease, epilepsy, and schizophrenia. As of June 30, 2020, it had participated in approximately 1,800 academic research studies in approximately 200 indications. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is based in Fitzroy, Australia.

Key Metrics

PE ratio


PB ratio


Dividend yield



Market cap


Enterprise value


Company profile

Primary activitiesCogstate Ltd (ASX:CGS) is a neuroscience technology company optimising brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Cogstate technologies provide rapid, reliable and highly sen
Industry / SectorHealth Information Services / Healthcare
Full time employees163
Mailing address425 Smith Street Suite 117 Fitzroy VIC 3065 Australia
Phone / Fax61 3 9664 1300 / 61 3 9664 1301


Cogstate does not pay dividends.

Company Executives

As of May 2021, following are the company executives and directors listed on Cogstate.

NameTitleAgeTotal Pay
Mr. Bradley O'Connor C.A., B.Bus, CACEO, MD & Exec. Director885.03k
Prof. Paul MaruffFounder & Chief Innovation Officer476.91k
Mr. John Glueck B.A., J.D.Gen. Counsel257.6k
Mr. Kenneth BillardChief Commercial Officer560.25k
Mr. Darren WatsonChief Financial Officer
Mr. Benjamin BloomfieldChief Technology Officer
Dr. Chris Edgar Ph.D.Chief Science Officer
Ms. Rachel ColiteVP of Strategic Initiatives, Communication & People
Mr. Keith Hawkins CPAFinancial Controller
Mr. David James Franks B.Ec, BEc, CA, F Fin, JP.Company Sec.50

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Cogstate is 140.21M and its enterprise value is 123.24M. The enterprise value to revenue ratio of CGS is 4.28.

Companies similar to Cogstate (CGS)

Cogstate (ASX:CGS) Frequently Asked Questions

1. What is Cogstate's Stock Symbol?

Cogstate trades on ASX under the ticker symbol "CGS".

2. What is Cogstate's stock price today?

One share of CGS stock can currently be purchased for approximately $0.82.

3. How can I contact Cogstate?

Cogstate's mailing address is 425 Smith Street Suite 117 Fitzroy VIC 3065 Australia. The company can be reached via phone at 61 3 9664 1300.

4. What is Cogstate's official website?

The official website of Cogstate is

5. Which share registry manages Cogstate's stock?

Cogstate's stock is managed by LINK MARKET SERVICES LIMITED.